Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.73 Analyst target: $4.00 Upside: 46.52%
Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is headquartered in Seattle, Washington.
See the full interactive analysis & chart →Informational only — not investment advice.